TWI PHARMS FDA Approval ANDA 202393

ANDA 202393

TWI PHARMS

FDA Drug Application

Application #202393

Application Sponsors

ANDA 202393TWI PHARMS

Marketing Status

Prescription001

Application Products

001SOLUTION;TOPICAL1.5%0DICLOFENAC SODIUMDICLOFENAC SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2014-11-24
LABELING; LabelingSUPPL2AP2021-04-28STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null7

TE Codes

001PrescriptionAT

CDER Filings

TWI PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202393
            [companyName] => TWI PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"DICLOFENAC SODIUM","activeIngredients":"DICLOFENAC SODIUM","strength":"1.5%","dosageForm":"SOLUTION;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/24\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2014-11-24
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.